| The Microcyn® Technology
has been successfully used around the world beginning
in 2005 to treat a variety of human wounds including
diabetic foot ulcers, burns, stasis and pressure
ulcers, traumatic wounds and more. The following
are first-person video accounts of a few of the
more than 750,000 patients who have been treated
with the various global Microcyn brands including
Dermacyn™, Microcyn60™ and Oxum™–without
a single report of a serious adverse effect.
Cheryl
Bongiovanni, Ph.D, RVT
Lake District Hospital
Lakeview, Oregon
|
»Play |
»Play |
|
Cheryl
Bongiovanni, Ph.D, RVT
Lake
District Hospital
Lakeview, Oregon
|
»Play |
»Play |
|
Matt
Regulski, DPM
Ocean
County Foot and Ankle
Toms
River, New Jersey
|
»Play |
»Play |
|
Tom Wolvos, MD
Scottsdale Surgical Consultants
Scottsdale, Arizona
|
»Play |
»Play |
|
David
Allie, MD
Cardiovascular
Institute of the South
Lafayette, Louisiana
|
»Play |
»Play |
|
|
|
|
|
|
|
